Indeed, several studies, including a meta-analysis of 38 retrospective studies assessing 8067 epithelial ovarian cancer cases, demonstrated that ABCB1 over-expression was a significant risk factor associated with unfavorable overall and progression-free survival [45,46]. This evidence concerns the gene ABCB1 and ovarian carcinoma.